Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-01-02 4:19 pm Sale | 13G | Sonnet BioTherapeutics Holdings Inc. SONN | Markey John | 198,300 6.500% | -32,815 (-14.20%) | View |
| 2023-11-17 11:32 am Purchase | 13G | Sonnet BioTherapeutics Holdings Inc. SONN | Markey John | 231,115 7.600% | 35,335 (+18.05%) | View |
| 2023-11-06 11:35 am Purchase | 13G | Sonnet BioTherapeutics Holdings Inc. SONN | Markey John | 195,780 6.400% | 195,780 (New Position) | View |
| 2023-08-07 07:00 am Purchase | 13G | Sonnet BioTherapeutics Holdings Inc. SONN | Markey John | 4,100,000 10.700% | 400,000 (+10.81%) | View |
| 2023-07-17 07:00 am Purchase | 13G | Sonnet BioTherapeutics Holdings Inc. SONN | Markey John | 3,700,000 11.100% | 395,000 (+11.95%) | View |
| 2023-07-07 07:00 am Purchase | 13G | Sonnet BioTherapeutics Holdings Inc. SONN | Markey John | 3,305,000 9.900% | 475,000 (+16.78%) | View |
| 2023-06-30 08:40 am Purchase | 13G | Sonnet BioTherapeutics Holdings Inc. SONN | Markey John | 2,830,000 8.500% | 110,000 (+4.04%) | View |
| 2023-06-22 2:49 pm Purchase | 13G | Sonnet BioTherapeutics Holdings Inc. SONN | Ruck Matthew J | 1,700,000 6.180% | 96,994 (+6.05%) | View |
| 2023-06-14 2:42 pm Unchanged | 13G | Sonnet BioTherapeutics Holdings Inc. SONN | Ruck Matthew J | 1,603,006 5.830% | 0 (Unchanged) | View |
| 2023-06-14 10:41 am Purchase | 13G | Sonnet BioTherapeutics Holdings Inc. SONN | Ruck Matthew J | 1,603,006 5.830% | 55,580 (+3.59%) | View |
| 2023-06-12 10:39 am Purchase | 13G | Sonnet BioTherapeutics Holdings Inc. SONN | Markey John | 2,720,000 9.900% | 420,000 (+18.26%) | View |
| 2023-06-09 10:42 am Purchase | 13G | Sonnet BioTherapeutics Holdings Inc. SONN | Ruck Matthew J | 1,547,426 5.600% | 1,547,426 (New Position) | View |
| 2023-05-26 10:23 am Purchase | 13G | Sonnet BioTherapeutics Holdings Inc. SONN | Markey John | 2,300,000 8.400% | 419,161 (+22.29%) | View |
| 2023-05-17 3:49 pm Purchase | 13G | Sonnet BioTherapeutics Holdings Inc. SONN | Markey John | 1,880,839 6.850% | 560,332 (+42.43%) | View |
| 2023-05-01 9:49 pm Purchase | 13G | Sonnet BioTherapeutics Holdings Inc. SONN | Markey John | 1,320,507 6.500% | 1,320,507 (New Position) | View |
| 2023-02-10 4:40 pm Unchanged | 13G | Sonnet BioTherapeutics Holdings Inc. SONN | Hudson Bay Capital Management LP | 242,856 2.970% | 0 (Unchanged) | View |
| 2022-02-03 2:30 pm Purchase | 13G | Sonnet BioTherapeutics Holdings Inc. SONN | Hudson Bay Capital Management LP | 3,400,000 5.340% | 3,400,000 (New Position) | View |
| 2021-03-10 07:51 am Purchase | 13G | Sonnet BioTherapeutics Holdings Inc. SONN | Mohan Pankaj | 942,959 5.500% | 942,959 (New Position) | View |
| 2021-02-16 3:53 pm Sale | 13G | Sonnet BioTherapeutics Holdings Inc. SONN | Arena Investors LP | 0 0.000% | -1,500,000 (Position Closed) | View |
| 2021-02-16 07:32 am Purchase | 13G | Sonnet BioTherapeutics Holdings Inc. SONN | Altium Capital Management LP | 5,664,728 4.990% | 5,126,638 (+952.75%) | View |